摘要
目的探讨磷酸化需肌醇酶1(p-IRE1)蛋白在鼻咽癌组织中的表达及其与放射治疗预后的相关性。方法选取2010年1月至2011年12月在我院首次行根治性调强放射治疗的鼻咽癌患者53例,免疫组化SP法检测鼻咽癌组织中p-IRE1蛋白表达水平,观察鼻咽癌患者放射治疗后生存期,分析p-IRE1蛋白表达水平与鼻咽癌患者临床病理特征、预后的关系。结果 53例鼻咽癌组织中p-IRE1阳性表达36例(67.9%),高表达14例(26.4%);p-IRE1蛋白表达水平与淋巴分期相关(P=0.033);多因素分析显示p-IRE1蛋白表达水平(P=0.026)、是否联合化疗(P=0.020)是鼻咽癌放射治疗的独立预后因素,p-IRE1高表达鼻咽癌患者放射治疗后死亡风险是低表达组的2.979倍。结论 p-IRE1蛋白可成为预测鼻咽癌放射治疗预后的新指标。
Objective To investigate the expression of phosphorylated inositol requiring enzyme 1 (p-IRE1) protein in nasopharyngeal carcinoma (NPC), and explore the relationship between the expression of p-IRE 1 and radiotherapy prognosis. Methods A total of 53 eases of NPC who re- ceived radical intensity-modulated radiation therapy in our hospital from January 2010 to December 2011 were retrospectively analyzed. P-IRE1 protein expression in cancer tissue was detected by immunohistochemistry. The survival time of patients with NPC after radiotherapy were recorded. The correlation between p-IRE1 expression with clinical pathological data and radiation prognosis in NPC was analyzed. Results Among the 53 patients, 36 eases (67.9%) were positive for p-IRE 1 staining, and 14 eases (26.4%) were highly expressed. P-IRE 1 protein expression was eoroelated with N stage (P = 0.033 ) ; Multivariable Cox analysis revealed that p-IRE 1 protein expression (P = 0.026 ) and chemotherapy (P = 0.020) were independent prognostic factors of radiotherapy. The death risk in patients after radiotherapy in high expression group is 2.979 times higher than low expression group. Conclusion P-IRE1 protein could be a new prognostic indicator of NPC.
作者
王欢
乔俏
解海涛
勾宏图
李光
WANG Huan QIAO Qiao XIE Haitao GOU Hongtu LI Guang(Department of Radiation Oncology, The First Hospital, China Medical University, Shenyang 110001, China)
出处
《中国医科大学学报》
CAS
CSCD
北大核心
2016年第10期926-931,共6页
Journal of China Medical University
关键词
鼻咽癌
磷酸化需肌醇酶1蛋白
放射治疗
预后
nasopharyngeal carcinoma
phosphorylated inositol requiring enzyme 1
radiotherapy
prognosis